Note 5. Segment Reporting (Segments Statements of Operations) (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]
Product revenue	$ 3,151,651	$ 2,724,740	$ 9,360,219	$ 8,635,078
Revenues, net	3,151,651	2,724,740	9,360,219	8,635,078
Cost of goods sold	1,473,334	1,337,442	4,539,870	4,309,894
Marketing, general and administrative	1,250,159	1,409,274	3,743,548	4,303,775
Research and development	315,850	272,889	1,016,082	803,256
Total costs and expenses	3,039,343	3,019,605	9,299,500	9,416,925
Loss from operations	112,308	(294,865)	60,719	(781,847)
Other Nonoperating Income (Expense)	0	11,033	7,543	79,770
Interest Expense	0	0	0	(79,479)
Total other (expense) income	46	11,104	7,707	423
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	113,000	(283,761)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest	112,354	(283,761)	68,426	(781,424)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations	112,354	(283,761)	68,426	(781,424)
Income (Loss) from Continuing Operations Attributable to Parent	113,000	(283,761)
Sonomed-Escalon [Member]
Segment Reporting Information [Line Items]
Product revenue	3,151,651	2,724,740	9,360,219	8,635,078
Revenues, net	3,151,651	2,724,740	9,360,219	8,635,078
Cost of goods sold	1,473,334	1,337,442	4,539,870	4,309,894
Marketing, general and administrative	1,166,277	1,339,879	3,497,883	4,022,842
Research and development	315,850	272,889	1,016,082	803,256
Total costs and expenses	2,955,461	2,950,000	9,053,835	9,135,992
Loss from operations	197,000	(225,470)	306,384	(500,914)
Other Nonoperating Income (Expense)	0	0	0	0
Interest Expense			0	0
Total other (expense) income	0	0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	197,000	(225,470)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			306,384	(500,914)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			306,384	(500,914)
Income (Loss) from Continuing Operations Attributable to Parent	196,190	(225,470)
Corporate [Member]
Segment Reporting Information [Line Items]
Product revenue	0	0	0	0
Revenues, net	0	0	0	0
Cost of goods sold	0	0	0	0
Marketing, general and administrative	83,882	69,395	245,665	280,933
Research and development	0	0	0	0
Total costs and expenses	18,752	148,686	245,665	280,933
Loss from operations	(83,882)	(69,395)	(245,665)	(280,933)
Other Nonoperating Income (Expense)	0	11,000	7,543	79,770
Interest Expense			0	(79,479)
Total other (expense) income	46	11,104	7,707	423
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(84,000)	(58,000)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			(237,958)	(280,510)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			(237,958)	(280,510)
Income (Loss) from Continuing Operations Attributable to Parent	$ (83,836)	$ (58,291)